Medications & Supplements/Prescription Drugs

Ideal Pharmacy Medroxyprogesterone Acetate Injection Recalled for Sterility

Agency Publication Date: January 31, 2022

Summary

Ideal Pharmacy is recalling approximately 57,994 vials of Medroxyprogesterone Acetate Injection (150 mg/mL), a prescription injectable medication. The recall was initiated because of a lack of assurance of sterility, meaning the manufacturer cannot guarantee the product is free from contamination. No incidents or injuries have been reported to date, and the medication was distributed to specialty pharmacies nationwide.

Risk

Administering a medication that is not sterile can lead to serious and potentially life-threatening infections, including abscesses at the injection site or systemic infections throughout the body.

What You Should Do

This recall affects Medroxyprogesterone Acetate Injection, IM (150 mg/mL) packaged in 1 ml single-dose vials under the Ideal Pharmacy brand (2333 Morris Ave, Union, NJ 07083).
All lots that are currently within their expiration dates are included in this recall.
If you have health concerns, contact your healthcare provider or pharmacist. Return any unused product to the place of purchase for a refund, throw it away, or contact Ideal Specialty Apothecary, Inc. dba Ideal Pharmacy for further instructions.
For additional questions, call the FDA Consumer Complaint hotline at 1-888-723-3332 (1-888-SAFEFDA) or visit the FDA website at www.fda.gov/safety/recalls.

Your Remedy Options

You have 2 options:

Option 1: Full Refund

How to: Contact your healthcare provider or pharmacist for guidance, or return any unused product to the place of purchase for a refund

Option 2: Dispose of Product

How to: Throw the product away. For prescription medications, a DEA take-back location or pharmacy mail-back program is preferred when available.

Affected Products

Product: Medroxyprogesterone Acetate Injection (150 mg/mL)

Variants: IM, 150 mg/mL, 1 ml Single Dose Vial, RX Only

Lot Numbers:

All lots within expiry

Recall #: D-0463-2022. Quantity: 57,994 vials. Distributed by Ideal Pharmacy, 2333 Morris Ave, Union, NJ 07083.

Additional Information

Agency: Food and Drug Administration (FDA)

Event ID: 89270

Status: Active

Manufacturer: Ideal Specialty Apothecary, Inc. dba Ideal Pharmacy

Sold By: Ideal Pharmacy; Specialty pharmacies

Manufactured In: United States

Units Affected: 57,994 vials

Distributed To: Nationwide

Were You Affected by This Recall?

If you or a family member were harmed by this recalled product, you may have legal rights. Consider consulting a consumer protection attorney to understand your options for compensation.

Find an Attorney

This is general information, not legal advice. Go Backs is not a law firm and does not provide legal services.

AI-Enhanced Content: The summary, action steps, and risk assessment on this page were generated by AI from official government recall data to improve readability. This is not legal or medical advice. Always refer to the official agency sources below for authoritative information.

Sources: FDA iRES · Raw API Response

openFDA Disclaimer: This recall information is sourced from the openFDA API. Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. Refer to the openFDA terms of service for more information.

Summary

What You Should Do

This recall affects Medroxyprogesterone Acetate Injection, IM (150 mg/mL) packaged in 1 ml single-dose vials under the Ideal Pharmacy brand (2333 Morris Ave, Union, NJ 07083).

All lots that are currently within their expiration dates are included in this recall.

If you have health concerns, contact your healthcare provider or pharmacist. Return any unused product to the place of purchase for a refund, throw it away, or contact Ideal Specialty Apothecary, Inc. dba Ideal Pharmacy for further instructions.

For additional questions, call the FDA Consumer Complaint hotline at 1-888-723-3332 (1-888-SAFEFDA) or visit the FDA website at www.fda.gov/safety/recalls.